Inventor
RODRIGO GUSTAV
SE35 patents
⚠️ This page may combine multiple inventors who share the name “RODRIGO GUSTAV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GE HEALTHCARE BIOPROCESS R&D AB
15 patentsUS10730908B2Aug 4, 2020
Separation method
GE HEALTHCARE BIOPROCESS R&D AB18 citations92
US10501557B2Dec 10, 2019
Mutated immunoglobulin-binding polypeptides
GE HEALTHCARE BIOPROCESS R&D AB13 citations92
US10343142B2Jul 9, 2019
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
GE HEALTHCARE BIOPROCESS R&D AB4 citations83
US10213765B2Feb 26, 2019
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
GE HEALTHCARE BIOPROCESS R&D AB7 citations83
US9896486B2Feb 20, 2018
Mutated immunoglobulin-binding polypeptides
GE HEALTHCARE BIOPROCESS R&D AB5 citations83
US9663559B2May 30, 2017
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
GE HEALTHCARE BIOPROCESS R&D AB5 citations83
US10815269B2Oct 27, 2020
Multimodal anion exchange matrices
GE HEALTHCARE BIOPROCESS R&D AB8 citations80
US10308690B2Jun 4, 2019
Mutated immunoglobulin-binding polypeptides
GE HEALTHCARE BIOPROCESS R&D AB5 citations76
US10208091B2Feb 19, 2019
Modified kappa light chain-binding polypeptides
GE HEALTHCARE BIOPROCESS R&D AB1 citations73
US10208092B2Feb 19, 2019
Modified kappa light chain-binding polypeptides
GE HEALTHCARE BIOPROCESS R&D AB3 citations73
US10189891B2Jan 29, 2019
Affinity chromatography matrix
GE HEALTHCARE BIOPROCESS R&D AB2 citations72
US11718643B2Aug 8, 2023
Multimodal anion exchange matrices
GE HEALTHCARE BIOPROCESS R&D AB0 citations59
US10112980B2Oct 30, 2018
Mutated immunoglobulin-binding polypeptides
GE HEALTHCARE BIOPROCESS R&D AB0 citations51
US10124328B2Nov 13, 2018
Separation method and separation matrix
GE HEALTHCARE BIOPROCESS R&D AB1 citations49
US9573973B2Feb 21, 2017
Separation method and separation matrix
GE HEALTHCARE BIOPROCESS R&D AB1 citations49
CYTIVA BIOPROCESS R & D AB
10 patentsUS11566082B2Jan 31, 2023
Mutated immunoglobulin-binding polypeptides
CYTIVA BIOPROCESS R & D AB7 citations85
US11136359B2Oct 5, 2021
Mutated immunoglobulin-binding polypeptides
CYTIVA BIOPROCESS R & D AB9 citations84
US11517879B2Dec 6, 2022
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
CYTIVA BIOPROCESS R & D AB2 citations72
US11667671B2Jun 6, 2023
Separation method
CYTIVA BIOPROCESS R & D AB2 citations71
US12337293B2Jun 24, 2025
Chromatography ligand comprising domain c from Staphylococcus aureus protein a for antibody isolation
CYTIVA BIOPROCESS R & D AB0 citations62
US12221492B2Feb 11, 2025
Mutated immunoglobulin-binding polypeptides
CYTIVA BIOPROCESS R & D AB0 citations62
US11680081B2Jun 20, 2023
Method for preparation of a separation matrix
CYTIVA BIOPROCESS R & D AB0 citations62
US11136357B2Oct 5, 2021
Modified kappa light chain-binding polypeptides
CYTIVA BIOPROCESS R & D AB0 citations62
US10875007B2Dec 29, 2020
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
CYTIVA BIOPROCESS R & D AB0 citations51
US12552857B2Feb 17, 2026
Method for separation of antibodies or antibody fragments being devoid of an Fc region capable of binding to protein A
CYTIVA BIOPROCESS R & D AB0 citations47